Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus
Top Cited Papers
Open Access
- 1 May 2014
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 174 (5), 773-785
- https://doi.org/10.1001/jamainternmed.2014.348
Abstract
Diabetes mellitus (DM) is increasing in prevalence worldwide and afflicts an estimated 6.6% of the global adult population, or approximately 285 million individuals. By 2030, an estimated 350 million people worldwide will be living with DM.1,2Keywords
This publication has 27 references indexed in Scilit:
- Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patientsEuropean Heart Journal, 2012
- The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathyKidney International, 2012
- Reno-protective effects of renin–angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysisDiabetologia, 2011
- Executive Summary: Standards of Medical Care in Diabetes—2012Diabetes Care, 2011
- Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled studyDiabetologia, 2011
- Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trialThe Lancet, 2008
- Telmisartan to Prevent Recurrent Stroke and Cardiovascular EventsNew England Journal of Medicine, 2008
- Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialThe Lancet, 2007
- Role of the Renin-Angiotensin-Aldosterone System and Proinflammatory Mediators in Cardiovascular DiseaseThe American Journal of Cardiology, 2006
- Prevention and Treatment of Diabetic Renal Disease in Type 2 DiabetesJournal of the American Society of Nephrology, 2006